Back to search

Article

Tumor Immune Cell Infiltration Patterns and Predictable Clinical Benefit with Nivolumab in Combination with Ipilimumab for 3P Implementation

2022-02-07

Abstract excerpt

<title>Abstract</title> <p>Background The combination immunotherapy (CIT), administering both nivolumab and ipilimumab, has demonstrated the durable efficacy in patients with skin cutaneous melanoma (SKCM), kidney renal cell carcinoma (KIRC), and lung adenocarcinoma (LUAD). However, the survival benefits of the CIT vary among responders according to tumor type and thus, the biomarker development for CIT is neces...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
269bfa76-efcf-542b-b542-4b42ea213098
DOI
10.21203/rs.3.rs-986280/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Tumor Immune Cell Infiltration Patterns and Predictable Clinical Benefit with Nivolumab in Combination with Ipilimumab for 3P ImplementationDOI 10.21203/rs.3.rs-986280/v1
Development and Performance of a CD8 Gene Signature for Characterizing Inflammation in the Tumor Microenvironment across Multiple Tumor TypesSemantic proximity
Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade.Semantic proximity
Immune Checkpoints are Predominantly Co-Expressed by Clonally Expanded CD4+FoxP3+ Intratumoral T-cells in Primary Human CancersSemantic proximity
Immune cell networks uncover candidate biomarkers of cancer immunotherapy responseSemantic proximity
Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockadeSemantic proximity
A mutational signature and significantly mutated driver genes associated with immune checkpoint inhibitor response across multiple cancers.Semantic proximity
Integrating Immune Multi-Omics and Machine Learning to Improve Prognosis, Immune Landscape, and Sensitivity to First- and Second-Line Treatments for Head and Neck Squamous Cell CarcinomaSemantic proximity
Pan-cancer prediction of tumor immune activation and response to immune checkpoint blockade from tumor transcriptomics and histopathologySemantic proximity
Machine learning-based identification of an immunotherapy-related signature to enhance outcomes and immunotherapy responses in melanomaSemantic proximity
Immune Landscape of Invasive Ductal Carcinoma Tumor Microenvironment Identifies a Prognostic and Immunotherapeutically Relevant Gene SignatureSemantic proximity
Identification and Utilization of Biomarkers to Predict Response to Immune Checkpoint Inhibitors.Semantic proximity
The Predictive and Prognostic Value of T- and B-cell Transcriptomic Signatures for Clinical Response to Immune Checkpoint Blockade in Pleural MesotheliomaSemantic proximity
Select a neighboring publication to make it the new centre.